Utilization of Previously Treated Patients (PTPs), Noninfected Patients (NIPs), and Previously Untreated Patients (PUPs) in the Evaluation of New Factor VIII and Factor IX Concentrates

Gilbert C. White; Donna DiMichele; Koen Mertens; Claude Negrier; Ian R. Peake; Christopher Prowse; Ranier Schwaab; Akira Yoshioka; Jørgen Ingerslev

doi:10.1055/s-0037-1614495

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1999; 81(03): 462
DOI: 10.1055/s-0037-1614495

Scientific and Standardization Committee Communications

Schattauer GmbH

Utilization of Previously Treated Patients (PTPs), Noninfected Patients (NIPs), and Previously Untreated Patients (PUPs) in the Evaluation of New Factor VIII and Factor IX Concentrates

Recommendation of the Scientific Subcommittee on Factor VIII and Factor IX of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis

Gilbert C. White

,

Donna DiMichele

,

Koen Mertens

,

Claude Negrier

,

Ian R. Peake

,

Christopher Prowse

,

Ranier Schwaab

,

Akira Yoshioka

,

Jørgen Ingerslev Chairman

Abstract

Full Text

References

References
1 Rosendaal FR. et al. A sudden increase in factor VIII inhibitor development in multitransfused hemophilia A patients in The Netherlands. Dutch Hemophilia Study Group. Blood 1993; 81: 2180-6.
2 Peerlinck K. et al. Factor VIII inhibitors in previously treated haemophilia A patients with a double viruS-inactivated plasma derived factor VIII concentrate. Thromb Haemost 1997; 77: 80-6.